Serum Albumin on Admission: A Prognostic Marker of Morbidity and Mortality in Burns? A Systematic Review and Meta-Analysis
Journal of Burn Care & Research · 2026
DOI: 10.1093/jbcr/irag092 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Burn Care & Research, 2026. Verfasst von Tiffany T S Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Burns Centre, Queen Elizabeth Hospital, Birmingham B15 2GW, United Kingdom. Hauptthemen laut MEDLINE: Burns, Serum Albumin. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Albumin is essential for maintaining oncotic pressure and vascular integrity. In burn injuries, increased capillary permeability leads to hypoalbuminemia, which is a recognized marker of poor outcomes in critical illness. However, its prognostic value in acute burn care remains underexplored. This study evaluated the prognostic value of admission serum albumin in predicting mortality, acute kidney injury (AKI), hospital and intensive care unit length of stay, ventilatory requirements, sepsis, and pulmonary infection in patients with burn injuries. A systematic search of PubMed, Scopus, Cochrane Library, Web of Science, MEDLINE, and Embase was conducted. Of 5587 studies screened, 19 were included in the systematic review and 9 in the meta-analysis. Statistical analysis was performed using RStudio, with pooled outcomes reported as odds ratios (ORs), standardized mean differences, and hierarchical summary receiver operating characteristic curves. Heterogeneity was assessed using Cochran’s Q, I2, and tau2. Hypoalbuminemia on admission was significantly associated with increased mortality during admission (OR 9.51; 95% CI, 3.04-29.78; I2 49.3%). Admission hypoalbuminemia was also associated with an increased risk of AKI (OR 2.83; 95% CI, 2.49-3.22; I2 0%). Evidence for other outcomes was limited and heterogeneous. Admission serum albumin appears to be a valuable prognostic marker in patients with burn injuries, particularly for mortality and AKI. Further research is required to support its integration into burn-specific risk models, characterize albumin trends within the first 24 h postinjury, and establish optimal cut-off values.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Burns Centre, Queen Elizabeth Hospital, Birmingham B15 2GW, United Kingdom.
- Heartlands Hospital, Birmingham B9 5SS, United Kingdom.
ORCID-Profile: Tiffany T S Ye, Sajeenth Vishnu K, Sarah E Bache
Zitieren
APA
Ye, T. T. S., Vishnu K, S., Dahil, A., Stewart, G., & Bache, S. E. (2026). Serum Albumin on Admission: A Prognostic Marker of Morbidity and Mortality in Burns? A Systematic Review and Meta-Analysis. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/irag092
Vancouver
Ye TTS, Vishnu K S, Dahil A, Stewart G, Bache SE. Serum Albumin on Admission: A Prognostic Marker of Morbidity and Mortality in Burns? A Systematic Review and Meta-Analysis. Journal of Burn Care & Research. 2026. doi:10.1093/jbcr/irag092
BibTeX
@article{Ye2026,
author = {Ye, Tiffany T S and Vishnu K, Sajeenth and Dahil, Angelica and Stewart, Gemma and Bache, Sarah E},
title = {Serum Albumin on Admission: A Prognostic Marker of Morbidity and Mortality in Burns? A Systematic Review and Meta-Analysis},
journal = {Journal of Burn Care & Research},
year = {2026},
doi = {10.1093/jbcr/irag092}
}
EUVIMED